Characteristics (n = 74) | No. of patients (%) |
---|---|
Age, median years (range) | 61 (21-79) |
Primary site | |
Ovary | 69 (93) |
Peritoneal | 2 (3) |
Fallopian tube | 3 (4) |
Original stage | |
Ic | 5 (7) |
IIb | 1 (1) |
IIc | 5 (7) |
IIIa | 4 (5) |
IIIb | 5 (7) |
IIIc | 45 (61) |
IV | 8 (11) |
Unknown | 1 (1) |
Tumor grade | |
Well differentiate | 11 (15) |
Moderate well differentiate | 21 (28) |
Poorly differentiate/undifferentiate | 36 (49) |
Unknown | 6 (8) |
Histologic type | |
Serous | 60 (81) |
Mucinous | 2 (3) |
Clear cell | 2 (3) |
Endometroid | 5 (7) |
Undifferentiate | 1 (1) |
Other | 4 (5) |
Response to firs line therapy | |
Complete response (CR) | 38 (51) |
Partial response (PR) | 8 (11) |
Stable disease (SD) | 2 (3) |
Non-evaluated disease (NED) | 26 (35) |
Time from end of first line chemotherapy to relapse | |
Median months (range) | 15.7 (6-80.9) |
Relapse between 6 to 12 months | 26 (35.1%) |
Relapse >12 months | 48 (64.9%) |